Caroline Rouvellat

  • Citations Per Year
Learn More
Bortezomib is a proteasome inhibitor commonly indicated for the treatment of multiple myeloma and non Hodgkin lymphoma. Cardiac adverse drug reactions of this drug are not clearly established. We report case where direct involvement of bortezomib in the occurrence of heart failure is strongly suspected and 22 other cases spontaneously reported to the French(More)
In a series of sequential studies from 2003 to 2007, we examined the quality of life in children with epilepsy, partial and generalized, on and off AEDs. All children came from a community-based practice referred to a paediatric neurologist (PAH) and were followed using standardized problem-oriented medical records. EEGs were all performed on Harmonie ,(More)
A 44 years-old diabetic male patient was admitted several times to the emergency department of Albi Hospital (France) for nocturnal hypoglycemias with losses of consciousness. The initial blood analysis, performed on a Cobas(®) analyzer, retrieved low levels of insulinemia. This patient was treated by analogues of insulin and did not present any(More)
  • 1